Biotech | May 07, 2022
Gut microbiome as a tool in regenerative medicine
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The Endosonography allows the use of EUS guided Fine needle aspiration for accurate diagnosis of GI cancers without the need for conventional biopsies
Complementary business models are the reason for the acquisition
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)